The authors summarize the major hurdles that have been overcome to deliver cell-based improvements in glucose control and highlight the key issues that stand between this important proof-of-concept clinical study and a durable cure for the majority of patients living with type 1 diabetes.
[NPJ Metabolic Health and Disease]